Irena Loryan
Universitetslektor vid Institutionen för farmaci; Farmakokinetik och Farmakodynamik; Translationell PKPD
- Besöksadress:
- Biomedicinskt Centrum BMC, Husargatan 3
- Postadress:
- Box 580
751 23 UPPSALA
Universitetslektor vid Institutionen för farmaci; Farmakokinetik och Farmakodynamik; Translationell PKPD
- Telefon:
- 018-471 49 95
- E-post:
- irena.loryan@farmbio.uu.se
- Besöksadress:
- Biomedicinskt Centrum BMC, Husargatan 3
- Postadress:
- Box 580
751 23 UPPSALA
Universitetslektor vid Institutionen för farmaci; Farmakokinetik och Farmakodynamik; Translationell PKPD
- E-post:
- irena.loryan@uu.se
- Besöksadress:
- Biomedicinskt Centrum BMC, Husargatan 3
- Postadress:
- Box 580
751 23 UPPSALA
- ORCID:
- 0000-0002-1557-4416
Nyckelord
- brain drug delivery
- neurodegeneration
- neuropharmacokinetics
- blood-brain barrier
- cns barriers
- blood-csf barrier
- blood-nerve barrier
- blood-dorsal root ganglia barrier
Biografi
Associate Professor (Docent) Irena Loryan is a researcher in the translational Pharmacokinetics-Pharmacodynamics (tPKPD) group in the Department of Pharmacy, Uppsala University, Sweden. She received her M.D. in 2001 and Ph.D. in pharmacology and biochemistry in 2007 from Yerevan State Medical University, Armenia. She then worked as a post-doctoral fellow at the Division of Pharmacogenetics at the Department of Pharmacology and Physiology, Karolinska Institutet (Prof. Magnus Ingelman-Sundberg Lab). Since 2011, she worked as a post-doctoral fellow at the Department of Pharmaceutical Biosciences, Uppsala University (Prof. Margareta Hammarlund-Udenaes Lab) in collaboration with Janssen Pharmaceutica, Beerse, Belgium. Her current research interest focuses on neuropharmacokinetics, implying mechanistic understanding of drug disposition in central and peripheral nervous systems involving passage across CNS and PNS barriers, distribution within parenchyma and elimination processes in health and disease, with focus on neurodegenerative diseases.

Publikationer
Urval av publikationer
Ingår i Pharmaceutical research, s. 1321-1341, 2022
- DOI för Unbound Brain-to-Plasma Partition Coefficient, K-p,K-uu,K-brain-a Game Changing Parameter for CNS Drug Discovery and Development
- Ladda ner fulltext (pdf) av Unbound Brain-to-Plasma Partition Coefficient, K-p,K-uu,K-brain-a Game Changing Parameter for CNS Drug Discovery and Development
Ingår i Molecular Psychiatry, s. 7732-7745, 2021
- DOI för Neuropharmacokinetic visualization of regional and subregional unbound antipsychotic drug transport across the blood-brain barrier.
- Ladda ner fulltext (pdf) av Neuropharmacokinetic visualization of regional and subregional unbound antipsychotic drug transport across the blood-brain barrier.
Ingår i Scientific Reports, 2019
- DOI för Heterogeneous drug tissue binding in brain regions of rats, Alzheimer’s patients and controls: impact on translational drug development
- Ladda ner fulltext (pdf) av Heterogeneous drug tissue binding in brain regions of rats, Alzheimer’s patients and controls: impact on translational drug development
Ingår i Molecular Psychiatry, s. 1527-1536, 2016
Ingår i Molecular Pharmaceutics, s. 520-532, 2015
Ingår i Pharmaceutical research, s. 2203-2219, 2014
The brain slice method for studying drug distribution in the CNS
Ingår i Fluids and Barriers of the CNS, s. 6, 2013
- DOI för The brain slice method for studying drug distribution in the CNS
- Ladda ner fulltext (pdf) av The brain slice method for studying drug distribution in the CNS
Senaste publikationer
Assessing central nervous system drug delivery
Ingår i Expert Opinion on Drug Delivery, s. 421-439, 2025
- DOI för Assessing central nervous system drug delivery
- Ladda ner fulltext (pdf) av Assessing central nervous system drug delivery
Ingår i International Journal of Antimicrobial Agents, 2025
- DOI för Ceftazidime-avibactam (CAZ-AVI) pharmacokinetics in critically ill patients undergoing continuous venovenous hemodiafiltration (CVVHDF)
- Ladda ner fulltext (pdf) av Ceftazidime-avibactam (CAZ-AVI) pharmacokinetics in critically ill patients undergoing continuous venovenous hemodiafiltration (CVVHDF)
Ingår i Toxicology, 2025
- DOI för The challenge to identify sensitive safety biomarkers of peripheral neurotoxicity in the rat: A collaborative effort across industry and academia (IMI NeuroDeRisk project)
- Ladda ner fulltext (pdf) av The challenge to identify sensitive safety biomarkers of peripheral neurotoxicity in the rat: A collaborative effort across industry and academia (IMI NeuroDeRisk project)
Ingår i Fluids and Barriers of the CNS, 2024
- DOI för Reduced oxycodone brain delivery in rats due to lipopolysaccharide-induced inflammation: microdialysis insights into brain disposition and sex-specific pharmacokinetics
- Ladda ner fulltext (pdf) av Reduced oxycodone brain delivery in rats due to lipopolysaccharide-induced inflammation: microdialysis insights into brain disposition and sex-specific pharmacokinetics
Ingår i Frontiers in Pharmacology, 2024
- DOI för Formulation-dependent differences in paclitaxel distribution to anatomical sites relevant to chemotherapy-induced peripheral neuropathy
- Ladda ner fulltext (pdf) av Formulation-dependent differences in paclitaxel distribution to anatomical sites relevant to chemotherapy-induced peripheral neuropathy
Alla publikationer
Artiklar i tidskrift
Ingår i International Journal of Antimicrobial Agents, 2025
- DOI för Ceftazidime-avibactam (CAZ-AVI) pharmacokinetics in critically ill patients undergoing continuous venovenous hemodiafiltration (CVVHDF)
- Ladda ner fulltext (pdf) av Ceftazidime-avibactam (CAZ-AVI) pharmacokinetics in critically ill patients undergoing continuous venovenous hemodiafiltration (CVVHDF)
Ingår i Toxicology, 2025
- DOI för The challenge to identify sensitive safety biomarkers of peripheral neurotoxicity in the rat: A collaborative effort across industry and academia (IMI NeuroDeRisk project)
- Ladda ner fulltext (pdf) av The challenge to identify sensitive safety biomarkers of peripheral neurotoxicity in the rat: A collaborative effort across industry and academia (IMI NeuroDeRisk project)
Ingår i Fluids and Barriers of the CNS, 2024
- DOI för Reduced oxycodone brain delivery in rats due to lipopolysaccharide-induced inflammation: microdialysis insights into brain disposition and sex-specific pharmacokinetics
- Ladda ner fulltext (pdf) av Reduced oxycodone brain delivery in rats due to lipopolysaccharide-induced inflammation: microdialysis insights into brain disposition and sex-specific pharmacokinetics
Ingår i Frontiers in Pharmacology, 2024
- DOI för Formulation-dependent differences in paclitaxel distribution to anatomical sites relevant to chemotherapy-induced peripheral neuropathy
- Ladda ner fulltext (pdf) av Formulation-dependent differences in paclitaxel distribution to anatomical sites relevant to chemotherapy-induced peripheral neuropathy
Active CNS delivery of oxycodone in healthy and endotoxemic pigs
Ingår i Fluids and Barriers of the CNS, 2024
- DOI för Active CNS delivery of oxycodone in healthy and endotoxemic pigs
- Ladda ner fulltext (pdf) av Active CNS delivery of oxycodone in healthy and endotoxemic pigs
Region-independent active CNS net uptake of marketed H+/ OC antiporter system substrates
Ingår i Frontiers in Cellular Neuroscience, 2024
- DOI för Region-independent active CNS net uptake of marketed H+/ OC antiporter system substrates
- Ladda ner fulltext (pdf) av Region-independent active CNS net uptake of marketed H+/ OC antiporter system substrates
Ingår i Journal of Headache and Pain, 2024
- DOI för Regional distribution of unbound eletriptan and sumatriptan in the CNS and PNS in rats: implications for a potential central action
- Ladda ner fulltext (pdf) av Regional distribution of unbound eletriptan and sumatriptan in the CNS and PNS in rats: implications for a potential central action
The solute carrier SLC7A1 may act as a protein transporter at the blood-brain barrier
Ingår i European Journal of Cell Biology, 2024
- DOI för The solute carrier SLC7A1 may act as a protein transporter at the blood-brain barrier
- Ladda ner fulltext (pdf) av The solute carrier SLC7A1 may act as a protein transporter at the blood-brain barrier
Ingår i Fluids and Barriers of the CNS, 2024
- DOI för Analysis of the contributing role of drug transport across biological barriers in the development and treatment of chemotherapy-induced peripheral neuropathy
- Ladda ner fulltext (pdf) av Analysis of the contributing role of drug transport across biological barriers in the development and treatment of chemotherapy-induced peripheral neuropathy
Differential Blood-Brain Barrier Transport and Cell Uptake of Cyclic Peptides In Vivo and In Vitro
Ingår i Pharmaceutics, 2023
- DOI för Differential Blood-Brain Barrier Transport and Cell Uptake of Cyclic Peptides In Vivo and In Vitro
- Ladda ner fulltext (pdf) av Differential Blood-Brain Barrier Transport and Cell Uptake of Cyclic Peptides In Vivo and In Vitro
Ingår i Pharmaceutical research, s. 2715-2730, 2023
- DOI för Active Uptake of Oxycodone at Both the Blood-Cerebrospinal Fluid Barrier and The Blood-Brain Barrier without Sex Differences: A Rat Microdialysis Study
- Ladda ner fulltext (pdf) av Active Uptake of Oxycodone at Both the Blood-Cerebrospinal Fluid Barrier and The Blood-Brain Barrier without Sex Differences: A Rat Microdialysis Study
Ingår i International Journal of Molecular Sciences, 2023
- DOI för Pharmacokinetics of Novel Dopamine Transporter Inhibitor CE-123 and Modafinil with a Focus on Central Nervous System Distribution
- Ladda ner fulltext (pdf) av Pharmacokinetics of Novel Dopamine Transporter Inhibitor CE-123 and Modafinil with a Focus on Central Nervous System Distribution
Ingår i Biomedicine and Pharmacotherapy, 2023
- DOI för Neurofilament light chain in plasma as a sensitive diagnostic biomarker of peripheral neurotoxicity: In Vivo mouse studies with oxaliplatin and paclitaxel - NeuroDeRisk project
- Ladda ner fulltext (pdf) av Neurofilament light chain in plasma as a sensitive diagnostic biomarker of peripheral neurotoxicity: In Vivo mouse studies with oxaliplatin and paclitaxel - NeuroDeRisk project
Brain barriers virtual: an interim solution or future opportunity?
Ingår i Fluids and Barriers of the CNS, 2022
- DOI för Brain barriers virtual: an interim solution or future opportunity?
- Ladda ner fulltext (pdf) av Brain barriers virtual: an interim solution or future opportunity?
Ingår i Pharmaceutical research, s. 1321-1341, 2022
- DOI för Unbound Brain-to-Plasma Partition Coefficient, K-p,K-uu,K-brain-a Game Changing Parameter for CNS Drug Discovery and Development
- Ladda ner fulltext (pdf) av Unbound Brain-to-Plasma Partition Coefficient, K-p,K-uu,K-brain-a Game Changing Parameter for CNS Drug Discovery and Development
Professor Margareta Hammarlund-Udenaes - Humbled Scientist Shaping Modern Neuropharmacokinetics
Ingår i Pharmaceutical research, s. 1283-1289, 2022
Ingår i Molecular Psychiatry, s. 7732-7745, 2021
- DOI för Neuropharmacokinetic visualization of regional and subregional unbound antipsychotic drug transport across the blood-brain barrier.
- Ladda ner fulltext (pdf) av Neuropharmacokinetic visualization of regional and subregional unbound antipsychotic drug transport across the blood-brain barrier.
Ingår i Archives of Toxicology, s. 2829-2845, 2020
- DOI för Molecular basis of mood and cognitive adverse events elucidated via a combination of pharmacovigilance data mining and functional enrichment analysis
- Ladda ner fulltext (pdf) av Molecular basis of mood and cognitive adverse events elucidated via a combination of pharmacovigilance data mining and functional enrichment analysis
Ingår i Pharmaceutics, 2019
- DOI för Amorphisation of Free Acid Ibuprofen and Other Profens in Mixtures with Nanocellulose: Dry Powder Formulation Strategy for Enhanced Solubility
- Ladda ner fulltext (pdf) av Amorphisation of Free Acid Ibuprofen and Other Profens in Mixtures with Nanocellulose: Dry Powder Formulation Strategy for Enhanced Solubility
Ingår i Scientific Reports, 2019
- DOI för Heterogeneous drug tissue binding in brain regions of rats, Alzheimer’s patients and controls: impact on translational drug development
- Ladda ner fulltext (pdf) av Heterogeneous drug tissue binding in brain regions of rats, Alzheimer’s patients and controls: impact on translational drug development
Ingår i Addiction Biology, s. 935-945, 2019
Ingår i Molecular Pharmaceutics, s. 3261-3274, 2019
Ingår i Molecular Pharmaceutics, s. 4362-4373, 2017
Ingår i Molecular Psychiatry, s. 1527-1536, 2016
Ingår i Molecular Pharmaceutics, s. 520-532, 2015
Effect of transporter inhibition on the distribution of cefadroxil in rat brain
Ingår i Fluids and Barriers of the CNS, 2014
- DOI för Effect of transporter inhibition on the distribution of cefadroxil in rat brain
- Ladda ner fulltext (pdf) av Effect of transporter inhibition on the distribution of cefadroxil in rat brain
Ingår i Pharmaceutical research, s. 2203-2219, 2014
The brain slice method for studying drug distribution in the CNS
Ingår i Fluids and Barriers of the CNS, s. 6, 2013
- DOI för The brain slice method for studying drug distribution in the CNS
- Ladda ner fulltext (pdf) av The brain slice method for studying drug distribution in the CNS
Sex difference in formation of propofol metabolites: a replication study
Ingår i Basic & Clinical Pharmacology & Toxicology, s. 126-131, 2013
Ingår i Clinical Pharmacology and Therapeutics, s. 221-227, 2012
Influence of sex on propofol metabolism, a pilot study: implications for propofol anesthesia
Ingår i European Journal of Clinical Pharmacology, s. 397-406, 2012
Artiklar, forskningsöversikt
Assessing central nervous system drug delivery
Ingår i Expert Opinion on Drug Delivery, s. 421-439, 2025
- DOI för Assessing central nervous system drug delivery
- Ladda ner fulltext (pdf) av Assessing central nervous system drug delivery
Kapitel i böcker, delar av antologi
Brain Distribution of Drugs: Pharmacokinetic Considerations
Ingår i Handbook of Experimental Pharmacology, Springer Berlin/Heidelberg, 2020
Drug Discovery Methods for Studying Brain Drug Delivery and Distribution
Ingår i Drug Delivery to the Brain, Springer, 2014
Drug discovery methods for studying brain drug delivery and distribution
Ingår i Drug delivery to the brain, s. 271-316, Springer, 2014